Aloxi^®

Aloxi^® (palonosetron hydrochloride) is a patented new generation 5-HT₃ antagonist, which is differentiated by its strength on initiation and the duration of its activity.

Aloxi^® obtained a centralised registration in Europe in 2005, with an indication for the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy, and the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.

Download the summary of product characteristics - (PDF)

UK

Mawdsleys
Unit 7
Parkway One Business Centre
Parkway Drive
Sheffield
S9 4WU
Tel: 0114 244 0321
Fax: 0114 243 6054
http://www.mawdsleys.co.uk/                          

E-mail: dave.hopkinson@mawdsleys.co.uk

Ireland

Cahill May Roberts
Pharmapark
Chapelizod
Dublin 20
Tel: 01 630 5304
Fax: 01 630 5589

E-mail: QuinnJ@cmrg.ie